Guidelines for AntiThrombotic Therapy
PMPH-USA Limited (Verlag)
978-1-60795-009-7 (ISBN)
- Keine Verlagsinformationen verfügbar
- Artikel merken
Thrombosis, an important complication of atherosclerosis and of various medical and surgical conditions, can be prevented and treated effectively by a variety of pharmacologic agents. With an update of previous editions publications, this book provides a summary of the 2004 American College of Chest Physicians (ACCP) recommendations, together with a brief review of the background data on which the recommendations are based. Literature searches were conducted by a recognized evidence-based center at McMaster University.
Jack Hirsh, MD Professor Emeritus in Medicine McMaster University Director Emeritus Henderson Research Centre Hamilton, Ontario
Introduction
1: Grades of Recommendations for Antithrombotic Drugs
2: Heparin and Low-Molecular-Weight Heparin
3: Oral Anticoagulants (Vitamin K Antagonists)
4: Platelet-Active Drugs
5: New Anticoagulants
6: Heparin-Induced Thrombocytopenia
7: Prevention of Venous Thromboembolism
8: Treatment of Venous Thromboembolism Disease
9: Atrial Fibrillation
10: Valvular Heart Disease
11: Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
12: Antithrombotic Therapy for Coronary Artery Disease
13: Intravenous Thrombolysis in Acute Myocardial Infarction
14: Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention
15: Coronary Artery Bypass Grafts
16: Antithrombotic Therapy in Peripheral Artery Occlusive Disease
17: Antithrombotic Therapy during Pregnancy
18: Antithrombotic Therapy in Children
| Verlagsort | Shelton |
|---|---|
| Sprache | englisch |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Hämatologie |
| ISBN-10 | 1-60795-009-X / 160795009X |
| ISBN-13 | 978-1-60795-009-7 / 9781607950097 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
